Beyond the Beam: A Radiation Oncology Curriculum for Radiopharmaceutical Therapy

Radiopharmaceutical therapies (RPTs) are increasingly utilized for treatment of prostate, neuroendocrine, thyroid and other cancers. Radiation oncologists are experts regarding the benefits and risks associated with various cancer radiotherapeutic options and are thus uniquely positioned to evaluate radiation treatment options for patients, including the use of RPTs. Radiation oncologists are designated authorized users for RPTs, but do not frequently prescribe RPTs or pursue development of RPT programs due to lack of training, infrastructure and knowledge of how to establish a program. The lack of training may affect patient safety and access to care, especially for new therapeutic radiopharmaceuticals since few practitioners are actively developing the RPT programs in the country. This curriculum will address the training need.

Target Audience

This activity is designed to meet the interests of radiation oncologists, radiation physicists, radiation biologists and radiation oncology residents.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Appraise the pharmacokinetics (PK) and biodistribution of radioisotopes used in therapy.
  • Articulate the instrumentation, mathematics, and radiation protection measures necessary for the safe and effective use
  • of radioactivity in RPT.
  • Articulate regulatory issues, standard operating procedures, and the process of becoming an authorized user in RPT,
  • emphasizing quality assurance, patient-centered care, and safety protocols.
Course summary
Available credit: 
  • 15.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 15.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 15.00 Certificate of Attendance
    This activity was designated for 15.00 AMA PRA Category 1 Credit™.
Course opens: 
04/01/2024
Course expires: 
07/04/2026
Cost:
$799.00
Rating: 
0

April 26, 2024 - Introduction, Radiobiology I and Chemistry

  • Introduction to Radiopharmaceutical Therapy and Curriculum Overview  Ana Kiess, MD, PhD
  • Radiobiology I (PK, Biodistribution, Dose Rate, Subcellular Targeting, Molecular and Cellular Effects of Beta/Alpha, Deterministic and Stochastic Effects, Toxicities)  Ana Kiess, MD, PhD
  • Chemistry of Radiopharmaceutical Therapies for Medical Use  Freddie E. Escorcia, MD, PhD

May 10, 2024 - Physics I and Principals of Clinical Molecular Imaging

  • Physics I – Image Acquisition and Quantitation (PET, SPECT)  Rameshwar Prasad, MS, PhD
  • Principles of Clinical Molecular Imaging for Radiopharmaceutical Therapy Vikas Prasad, MD, PhD

May 17, 2024 - Physics II-IV

  • Physics II – Instrumentation and Mathematics Pertaining to the Use and Measurement of Radioactivity  Rameshwar Prasad, MS, PhD
  • Physics III – Radiation Protection for Radiopharmaceutical Therapies  Jessica Clements, MS
  • Physics IV – Regulatory Issues and Standard Operating Procedures  Jacqueline Esthappan Zoberi, PhD

May 24, 2024 - Dosimetry I and II and Radiobiology II

  • Dosimetry I – Dosimetry Methods and Individual Dose Planning, Uncertainties Yuni Dewaraja, PhD
  • Dosimetry II/Radiobiology II – Bioeffect Modeling, Tumor Dose-Response, Toxicities, Alpha Emitters Robert Francois Hobbs, PhD

May 31, 2024 - Quality and Safety

  • Principles of Patient-Centered Clinical Radiopharmaceutical Therapy: Quality and Safety  Hyun Kim, MD

June 7, 2024 - Therapy-Specific Considerations I

  • Therapy-Specific Considerations for Lu-PSMA-617  Jeff M. Michalski, MD, MBA, FASTRO
  • Therapy-Specific Considerations for Ra-223  Richard G. Stock, MD

June 14, 2024 - Therapy-Specific Considerations II

  • Therapy-Specific Considerations for RAI  Stephanie S. Markovina, MD, PhD and Nikhil Rammohan, MD, PhD
  • Therapy-Specific Considerations for Liver-Directed Radiopharmaceutical Therapy/Selective Internal Radiation Therapy  Andrew Kennedy, MD

June 21, 2024 - Miscellaneous and Future Applications

  • Miscellaneous and Future Applications of Radiopharmaceutical Therapy – How to Become an Authorized User, Meta-iodobenzylguanidine, Rhenium Skin Cancer Therapy, Radiosynoviorthesis, Alpha Emitters, Other Michael Folkert, MD, PhD

July 5, 2024 - Therapy-Specific Considerations III

  • Therapy-Specific Considerations for Lu-DOTATATE  Hyun Kim, MD

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 15.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 15.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 15.00 Certificate of Attendance
    This activity was designated for 15.00 AMA PRA Category 1 Credit™.
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$799.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

Nonmember: $799
Member: $599
Member-in-training: $99
Member Student/Grad Student/PGY: $99
Member Postdoctoral Fellow: $99
 

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website until July 4, 2026, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.